A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

The death rate for gastric sleeve surgery is extremely low, with rates similar to those in Western countries. With advancements in laparoscopic surgery and highly trained bariatric surgeons, the mortality rate is estimated to be less than 0.1%. Most complications are manageable and arise from issues such as leaks or infections.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

An infection in the stomach is commonly caused by bacteria like H. pylori, which can lead to gastritis, ulcers, or even stomach cancer. Symptoms of a stomach infection include nausea, vomiting, diarrhea, and stomach pain. Treatment involves antibiotics and medications to reduce stomach acid and heal the stomach lining.